Patents by Inventor Philip Goliber

Philip Goliber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Naltrexone hydrochloride compositions
    Publication number: 20170100337
    Abstract: The present invention relates to compositions and methods of stabilizing naltrexone hydrochloride.
    Type: Application
    Filed: October 20, 2016
    Publication date: April 13, 2017
    Inventors: Benjamin Oshlack, Hua-Pin Huang, Philip Goliber, Richard Mannion
  • Controlled-release emulsion compositions
    Publication number: 20070104778
    Abstract: The present invention is directed to controlled-release composition containing a solubilized material comprising an active agent and at least one oil-based surfactant capable of solubilizing the active agent, the solubilized material dispersed in a controlled-release particulate matrix.
    Type: Application
    Filed: November 7, 2006
    Publication date: May 10, 2007
    Inventors: Hongxia Zeng, Antonio Moroni, Anand Baichwal, Philip Goliber, Sara Ketsela, Daniel McNamara
  • Sustained release formulations of nalbuphine
    Publication number: 20070048376
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: August 24, 2006
    Publication date: March 1, 2007
    Applicant: Penwest Pharmaceuticals Co.
    Inventors: Anand Baichwal, Philip Goliber, Anthony Carpanzano, Thomas Sciascia, Donald Diehl, Brian Vogler
  • Isomorphic crystalline habits of 3alpha-hydroxy-21-(1'-imidazolyl)-3beta-methoxymethyl-5alpha-pregnane-20-one
    Publication number: 20060074059
    Abstract: The present invention provides stable particles of 3a-hydroxy-21-(1?-imidazolyl)-3?-methoxymethyl-5a-pregnan-20-one (Compound I), which possess and retain a shape and size appropriate for handling and manufacture of large-scale pharmaceutical preparations, even in the absence of further milling. Further provided is a method for obtaining such reproducible, stable particles by subjecting crude Compound I to controlled crystallization conditions comprising slow cooling of a solution of Compound I. Further provided is a pharmaceutical composition of unmilled crystalline Compound I, which does not require milling prior to formulation, and a method of modulating brain excitability using the same.
    Type: Application
    Filed: August 25, 2005
    Publication date: April 6, 2006
    Inventors: Philip Goliber, Pauline Leary, Helen Danagher, Matthew Hartenstein
  • Naltrexone hydrochloride compositions
    Publication number: 20030229111
    Abstract: The present invention relates to compositions and methods of stabilizing naltrexone hydrochloride.
    Type: Application
    Filed: March 14, 2003
    Publication date: December 11, 2003
    Inventors: Benjamin Oshlack, Hua-Pin Huang, Philip Goliber, Richard Mannion